Aging does not occur evenly. While we may seem to age gradually at the same pace each year, molecular-level changes in the ...

How to cure cancer is the ultimate question – but meet the expert who says there are ways to outsmart it - HEALTH IN FOCUS : For the longest time, we thought of cancer as related to smoking or ...

Eli Lilly's new experimental weight loss drug retatrutide yielded up to 28% weight loss, which is greater than that of ...

Retatrutide, an experimental injectable drug, targets three hormones related to weight loss.

Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...

An estimated one in eight American adults are taking GLP-1 (glucagonlike peptide 1) drugs including Wegovy and Zepbound to treat conditions such as diabetes or to lose weight. Some experts believe ...

Eli Lilly on May 21 said its experimental weight-loss shot retatrutide delivered dramatic weight loss in a late-stage study of people with obesity. Lilly said people on the next-generation weight loss ...

For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight ...

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins An experimental shot helped participants ...